Featured Posts
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs,…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager…
Search Posts
Op-Eds
Want to Avoid GM Foods? This Regulation Won’t Help
Yesterday, the European Parliament’s Environment Committee voted to expand the EU’s labelling requirement for Genetically Modified foods. The measure, in the form of…
Op-Eds
Worrying About Frankenstein’s Monster
A specter is haunting Europe—called the “precautionary principle”. As generally defined, the precautionary principle states that a product or technology can be banned even if…
Citation
Cancer Doctors on the FDA
Op-Eds
Battling Hunger With Biotechnology
Needless restrictions on agricultural biotechnology would harm the world's ability to battle hunger in the 21st century, say Gregory Conko and C.S. Prakash, co-founders…
News Release
FDA Too Slow to Approve New Medical Drugs and Devices
A new nationwide poll of cancer specialists sponsored by the Competitive Enterprise Institute finds many of them believe the FDA is too slow in approving…
Washington Post